JADPRO / CME Supplements / Volume 10, Supplement 4 (Nov/Dec 2019)
Volume 10, Supplement 4 (Nov/Dec 2019) Cover
Volume 10, Supplement 4 (Nov/Dec 2019)

Volume 10, Supplement 4 (Nov/Dec 2019)

Optimizing Treatment and Improving Outcomes for Patients With Acute Myeloid Leukemia: A Guide for Advanced Practitioners

A continuing education activity for nurse practitioners, PAs, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.

This certified activity is supported by educational grants from Agios Pharmaceuticals, Inc. and Jazz Pharmaceuticals, Inc.

HSME Newlogo

JADPRO 5 Fig02

Previous All CME Supplements Next
Editorial

Acute Myeloid Leukemia: An Ever-Changing Disease

Abstract Acute myeloid leukemia is the most common form of acute leukemia in adults. In recent years, there has been robust characterization of molecular targets for drug development, leading to the U.S. Food & Drug Administration a...

December 23, 2019

Appendix

Appendix: Key Information on Newly Approved AML Drugs

This article is a part of a JADPRO certified supplement, Optimizing Treatment and Improving Outcomes for Patients With Acute Myeloid Leukemia: A Guide for Advanced Practitioners Table of Contents Acute Myeloid Leukemia: An Ever-Ch...

December 23, 2019

Current Issue
Sep/Oct 2024 Cover
Sep/Oct 2024 Cover Art
Vol 15 No 6 Sep/Oct 2024

Carcinoid Heart Disease

Nicole Kuhnly, MS, ACNPC-AG, Jessica Shank Coviello, DNP, APRN, ANP-BC, Catherine A. Kobza, MSN, AGACNP-BC, Et al.

September 16, 2024

Table of Contents Archive
Recent Issues
Volume 15, Number 6 (Sep/Oct 2024)
Volume 15, Number 5 (Jul/Aug 2024)
Volume 15, Number 4 (May/Jun 2024)
Volume 15, Number 3 (Apr 2024)